Long-term results (> 12 years) of surgical treatment of perihilar cholangiocarcinoma: Application of a modified Nagoya approach at a western center.

IF 2.2 3区 医学 Q2 SURGERY
İlgin Özden, Orhan Bilge, Nergiz Dağoğlu, Ayşen Yavru, Mine Güllüoğlu, Arzu Poyanlı, Yaman Tekant, Ahmet Kızir
{"title":"Long-term results (> 12 years) of surgical treatment of perihilar cholangiocarcinoma: Application of a modified Nagoya approach at a western center.","authors":"İlgin Özden, Orhan Bilge, Nergiz Dağoğlu, Ayşen Yavru, Mine Güllüoğlu, Arzu Poyanlı, Yaman Tekant, Ahmet Kızir","doi":"10.1007/s00423-026-04106-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To analyze the results of a modified Nagoya approach in perihilar cholangiocarcinoma at a western center.</p><p><strong>Methods: </strong>The first author trained for one year at Nagoya University. The records of the 53 patients who underwent major hepatobiliary resection between 2001 and 2012 were reviewed. All fundamental principles were strictly applied with following modifications: hepatoduodenal ligament dissection limited to the level cranial to the gastroduodenal artery; 8a-p lymph nodes removed only if macroscopically positive; adjuvant radiotherapy, chemoradiotherapy (CRT) and CRT followed by chemotherapy in selected patients starting in 2007,2009 and 2011 respectively. The results were compared with the 2021 international benchmark values.</p><p><strong>Results: </strong>Twenty-seven patients were men; median (range) age was 54 (29-74). Percutaneous biliary drainage was performed in 45 patients (85%) and portal vein embolization in 8 (15%). Portal vein resection was required in 10 patients (19%). The 90-day mortality was 4% (2/53). Perihepatic fluid infection without an obvious biliary leak was the most frequent complication (42%). The frequencies of liver failure B-C and bile leak were 8% and 12% respectively. The calculated 1,3,5 and 10 -year survival rates were 87%,62%, 41% and 25% respectively. Thirteen patients (25%) survived longer than 10 years: seven had T1 and six had T2a tumors; none had a poorly differentiated tumor, positive surgical margins or lymph node metastasis.</p><p><strong>Conclusions: </strong>The modified Nagoya approach yielded outcomes similar to 25th percentile values for 90-day mortality, postoperative liver failure B-C and bile leak and benchmark values for 5-year overall survival.</p>","PeriodicalId":17983,"journal":{"name":"Langenbeck's Archives of Surgery","volume":" ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2026-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13534225/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Langenbeck's Archives of Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00423-026-04106-2","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To analyze the results of a modified Nagoya approach in perihilar cholangiocarcinoma at a western center.

Methods: The first author trained for one year at Nagoya University. The records of the 53 patients who underwent major hepatobiliary resection between 2001 and 2012 were reviewed. All fundamental principles were strictly applied with following modifications: hepatoduodenal ligament dissection limited to the level cranial to the gastroduodenal artery; 8a-p lymph nodes removed only if macroscopically positive; adjuvant radiotherapy, chemoradiotherapy (CRT) and CRT followed by chemotherapy in selected patients starting in 2007,2009 and 2011 respectively. The results were compared with the 2021 international benchmark values.

Results: Twenty-seven patients were men; median (range) age was 54 (29-74). Percutaneous biliary drainage was performed in 45 patients (85%) and portal vein embolization in 8 (15%). Portal vein resection was required in 10 patients (19%). The 90-day mortality was 4% (2/53). Perihepatic fluid infection without an obvious biliary leak was the most frequent complication (42%). The frequencies of liver failure B-C and bile leak were 8% and 12% respectively. The calculated 1,3,5 and 10 -year survival rates were 87%,62%, 41% and 25% respectively. Thirteen patients (25%) survived longer than 10 years: seven had T1 and six had T2a tumors; none had a poorly differentiated tumor, positive surgical margins or lymph node metastasis.

Conclusions: The modified Nagoya approach yielded outcomes similar to 25th percentile values for 90-day mortality, postoperative liver failure B-C and bile leak and benchmark values for 5-year overall survival.

手术治疗肝门周围胆管癌的长期结果(bbb10 - 12年):改良名古屋入路在西部中心的应用。
目的:分析西部中心改良名古屋入路治疗肝门周围胆管癌的结果。方法:第一作者在名古屋大学进行了一年的培训。回顾了2001年至2012年间接受肝胆大切除术的53例患者的记录。所有基本原则均严格适用,但有以下修改:肝十二指肠韧带剥离限于颅至胃十二指肠动脉水平;8a-p淋巴结仅在宏观阳性时切除;选择的患者分别于2007年、2009年和2011年开始进行辅助放疗、放化疗(CRT)和CRT后化疗。结果与2021年的国际基准值进行了比较。结果:男性27例;年龄中位数(范围)为54岁(29-74岁)。经皮胆道引流45例(85%),门静脉栓塞8例(15%)。10例(19%)患者需要门静脉切除术。90天死亡率为4%(2/53)。无明显胆漏的肝周液感染是最常见的并发症(42%)。肝衰竭B-C和胆漏发生率分别为8%和12%。计算的1年、3年、5年和10年生存率分别为87%、62%、41%和25%。13例患者(25%)存活超过10年:7例T1, 6例T2a肿瘤;没有一例有低分化肿瘤、手术边缘阳性或淋巴结转移。结论:改良名古屋方法的结果与90天死亡率、术后肝功能衰竭B-C和胆漏的第25百分位值和5年总生存率的基准值相似。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.30
自引率
8.70%
发文量
342
审稿时长
4-8 weeks
期刊介绍: Langenbeck''s Archives of Surgery aims to publish the best results in the field of clinical surgery and basic surgical research. The main focus is on providing the highest level of clinical research and clinically relevant basic research. The journal, published exclusively in English, will provide an international discussion forum for the controlled results of clinical surgery. The majority of published contributions will be original articles reporting on clinical data from general and visceral surgery, while endocrine surgery will also be covered. Papers on basic surgical principles from the fields of traumatology, vascular and thoracic surgery are also welcome. Evidence-based medicine is an important criterion for the acceptance of papers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书